Stress management interventions can help to improve mental health for adults living with multiple sclerosis. However, uncontrolled study designs may overestimate intervention effects. A systematic search of the Embase, PsycINFO, PubMed, and Scopus databases identified eight randomized controlled trials evaluating cognitive behavioral approaches for a pooled sample of 568 adults with multiple sclerosis. Both group and individual-based stress management interventions appear to be effective in promoting self-management of stress. Further research is needed to confirm the optimal timing of stress management interventions across the MS spectrum and strategies to maintain intervention effects.
*AglandSLydonAShawS, et al. (2018) Can a stress management programme reduce stress and improve quality of life in people diagnosed with multiple sclerosis?Multiple Sclerosis Journal: Experimental, Translational and Clinical4(4): 1–4.
2.
ArtemiadisAKAnagnostouliMCAlexopoulosEC (2011) Stress as a risk factor for multiple sclerosis onset or relapse: A systematic review. Neuroepidemiology36(2): 109–120.
3.
*ArtemiadisAKVervainiotiAAAlexopoulosEC, et al. (2012) Stress management and multiple sclerosis: A randomized controlled trial. Archives of Clinical Neuropsychology27(4): 406–416.
4.
BellgAJBorrelliBResnickB, et al. (2004) Enhancing treatment fidelity in health behavior change studies: Best practices and recommendations from the NIH Behavior Change Consortium. Health Psychology23(5): 443–451.
5.
Benito-LeónJ (2011) Stress and multiple sclerosis: What’s new?Neuroepidemiology36(2): 121–122.
6.
BlankespoorRJSchellekensMPJVosSH, et al. (2017) The effectiveness of mindfulness-based stress reduction on psychological distress and cognitive functioning in patients with Multiple Sclerosis: A pilot study. Mindfulness8(5): 1251–1258.
7.
BogosianAHughesANortonS, et al. (2016) Potential treatment mechanisms in a mindfulness-based intervention for people with progressive multiple sclerosis. British Journal of Health Psychology21(4): 859–880.
8.
BorensteinMHedgesLVHigginsJP, et al. (2009) Introduction to meta-analysis. Chichester, U.K: John Wiley & Sons.
9.
BorensteinMHigginsJPTHedgesLV, et al. (2017) Basics of meta-analysis: I2 is not an absolute measure of heterogeneity. Research Synthesis Methods8: 5–18. DOI:10.1002/jrsm.1230.
10.
Briones-BuixassaLMilàRAragonèsJM, et al. (2015) Stress and multiple sclerosis: A systematic review considering potential moderating and mediating factors and methods of assessing stress. Health Psychology Open2(2): 1–16.
11.
CohenJ (1988) Statistical Power Analysis for the Behavioral Sciences (2nd edn). Hillsdale, NJ: Erlbaum.
12.
CummingG (2012) Understanding the New Statistics: Effect Sizes, Confidence Intervals, and Meta-Analysis. New York: Routledge.
13.
EggerMSmithGDSchneiderM, et al. (1997) Bias in meta-analysis detected by a simple, graphical test. British Medical Journal315(7109): 629–634.
14.
EllisPD (2010) The Essential Guide to Effect Sizes: Statistical Power, Meta-Analysis, and the Interpretation of Research Results. Cambridge: Cambridge University Press.
15.
FischerJSLaRoccaNGMillerDM, et al. (1999) Recent developments in the assessment of quality of life in multiple sclerosis (MS). Multiple Sclerosis5(4): 251–259.
16.
*FoleyFWBedellJRLaRoccaNG, et al. (1987) Efficacy of stress-inoculation training in coping with multiple sclerosis. Journal of Consulting and Clinical Psychology55(6): 919–922.
17.
FraserREhdeDAmtmannD, et al. (2013) Self-management for people with multiple sclerosis: Report from the first international consensus conference, november 15, 2010. International journal of MS care15(2): 99–106. doi:10.7224/1537-2073.2012-044
18.
FuRGartlehnerGGrantM, et al. (2011) Conducting quantitative synthesis when comparing medical interventions: AHRQ and the effective health care program. Journal of Clinical Epidemiology64: 1187–1197.
19.
GreensteinJI (2002) Problems in clinical trial design in multiple sclerosis. International Journal of MS Care4(3): 125–138.
20.
HartSLVellaLMohrDC (2008) Relationships among depressive symptoms, benefit-finding, optimism, and positive affect in multiple sclerosis patients after psychotherapy for depression. Health Psychology27: 230–238.
21.
HigginsJPTSterneJACSavovićJ, et al. (2016) A revised tool for assessing risk of bias in randomized trials. Cochrane Database of Systematic Reviews10(Suppl. 1): 29–31.
22.
HindDKaklamanouDBeeverD, et al. (2016) The assessment of depression in people with multiple sclerosis: A systematic review of psychometric validation studies. BMC Psychiatry16: 278.
23.
HróbjartssonAEmanuelssonFSkou ThomsenAS, et al. (2014) Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies. International Journal of Epidemiology43(4): 1272–1283.
24.
HuttonBSalantiSCaldwellDM, et al. (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Annals of Internal Medicine162(11): 777–784.
25.
JüniPHolensteinFSterneJ, et al. (2002) Direction and impact of language bias in meta analyses of controlled trials: Empirical study. International Journal of Epidemiology31(1): 115–123.
26.
Kabat-ZinnJ (1996) Mindfulness meditation: What it is, what it isn’t, and it’s role in health care and medicine. In: HarukiYIshiiYSuzukiM (eds) Comparative and Psychological Study on Meditation. Delft, NL: Eburon Publishers, pp. 161–169.
27.
*KolahkajBZargarF (2015) Effect of mindfulness-based stress reduction on anxiety, depression and stress in women with multiple sclerosis. Nursing and Midwifery Studies4(4): e29655.
28.
KurtzkeJF (1983) Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology33(11): 1444.
29.
LazarusRS (1991) Progress on a cognitive-motivational-relational theory of emotion. American Psychologist46: 819–834.
30.
LazarusRS (1999) Stress and Emotion: A New Synthesis. New York: Springer.
31.
LazarusRS (2000) Cognitive-motivational-relational theory of emotion. In: HaninYL (ed.) Emotions in Sport. Champaign, IL: Human Kinetics, pp. 39–63.
32.
LazarusSJFolkmanS (1984) Stress, Appraisal and Coping. New York: Springer.
33.
LiberatiAAltmanDTatzlaffJ, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. British Medical Journal339: b2700.
34.
LindenW (2005) Stress Management: From Basic Science to Better Practice. Thousand Oaks, CA: SAGE, pp. 83–140.
McCabeMPEbacioniKJSimmonsR, et al. (2015) Unmet education, psychological and peer support needs of people with multiple sclerosis. Journal of Psychosomatic Research78(1): 82–87.
37.
McDonaldWICompstonAEdanG, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology50: 121–127.
38.
McGuireKBStojanovic-RadicJStroberL, et al. (2015) Development and effectiveness of a psychoeducational wellness program for people with multiple sclerosis: Description and outcomes. International Journal of MS Care17: 1–8.
39.
MaidaSDalla CostaGRodegherM, et al. (2014) Overcoming recruitment challenges in patients with multiple sclerosis: Results from an Italian survey. Clinical Trials11(6): 667–672.
40.
MalcomsonKSDunwoodySLowe-StrongAS (2007) Psychosocial interventions in people with multiple sclerosis: A review. Journal of Neurology254: 1–13.
41.
MarrieRAZhangLLixLM, et al. (2018) The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis. Multiple Sclerosis and Related Disorders20: 9–15.
42.
MohrDC (2007) Stress and multiple sclerosis. Journal of Neurology254: II65–II68.
43.
MohrDCGoodkinDELikoskyW, et al. (1997) Identification of Beck Depression Inventory items related to multiple sclerosis. Journal of Behavioural Medicine20(4): 407–414.
44.
MohrDCHartSLJulianL, et al. (2004) Association between stressful life events and exacerbation in multiple sclerosis: A meta-analysis. British Medical Journal328(7442): 731.
45.
*MohrDCLoveraJBrownT, et al. (2012) A randomized trial of stress management for the prevention of new brain lesions in MS. Neurology79(5): 412–419.
46.
MunozSJAOreja -GuevaraCLorenzoS, et al. (2016) Psychotherapeutic and psychosocial interventions for managing stress in multiple sclerosis: The contribution of mindfulness-based interventions. Neurologia31(2): 113–120.
47.
OrwinRG (1983) A fail-safe N for effect size in meta-analysis. Journal of Educational Statistics8: 157–159.
48.
PagniniFBosmaCMPhillipsD, et al. (2014) Symptom changes in multiple sclerosis following psychological interventions: A systematic review. BMC Neurology14: 222.
49.
PeinemannFLabeitAMThielscherC, et al. (2014) Failure to address potential bias in non-randomised controlled clinical trialsmaycause lack of evidence on patient-reported outcomes: A method study. BMJ Open4: e004720.
50.
PhamBPlattRMcAuleyL, et al. (2001) Is there a “best” way to detect and minimize publication bias? An empirical evaluation. Evaluation & the Health Professions24(2): 109–125.
51.
PolmanCHReingoldSCBanwellB, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology69: 292–302.
52.
PolmanCHReingoldSCEdanG, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria.”Annals of Neurology58: 840–846.
53.
ReynardAKSullivanABRae-GrantA (2014) A systematic review of stress management interventions for multiple sclerosis patients. International Journal of MS Care16(3): 140–144.
54.
*SanaeinasabHSaffariMHashempourM, et al. (2017) Effect of a transactional model education program on coping effectiveness in women with multiple sclerosis. Brain and Behavior7: e00810.
55.
SchiavonCCMarchettiEGurgelLG, et al. (2017) Optimism and hope in chronic disease: A systematic review. Frontiers in Psychology7: 2022.
56.
SchwartzCE (1999) Teaching coping skills enhances quality of life more than peer support: Results of a randomized trial with multiple sclerosis patients. Health Psychology18: 211–220.
57.
SchweizerMLBraunBIMilstoneAM (2016) Research methods in healthcare epidemiology and antimicrobial stewardship-quasi-experimental designs. Infection Control & Hospital Epidemiology37(10): 1135–1140.
58.
SendersAHanesDBourdetteD, et al. (2014) Reducing survey burden: Feasibility and validity of PROMIS measures in multiple sclerosis. Multiple Sclerosis20(8): 1102–1111.
59.
*SendersAHanesDBourdetteD, et al. (2018) Impact of mindfulness-based stress reduction for people with multiple sclerosis at 8 weeks and 12 months: A randomized clinical trial. Multiple Sclerosis Journal25: 1178–1188.
60.
SeselALSharpeLNaismithSL (2018) Psychotherapy efficacy of psychosocial interventions for people with multiple sclerosis: A meta-analysis of specific treatment effects. Psychotherapy and Psychosomatics87(2): 105–111.
61.
SiegristJLiJ (2018) Work stress and the development of chronic diseases. International Journal of Environmental Research and Public Health15(3): 536.
62.
SimpsonRBoothJLawrenceM, et al. (2014) Mindfulness based interventions in multiple sclerosis—A systematic review. BMC Neurology14: 15.
63.
*SimpsonRMairFSMercerS (2017) Mindfulness-based stress reduction for people with multiple sclerosis—A feasibility randomised controlled trial. BMC Neurology17: 94.
64.
SkokouMSoubasiEGourzisP (2012) Depression in multiple sclerosis: A review of assessment and treatment approaches in adult and pediatric populations. ISRN Neurology2012: 427102.
65.
SterneJACSuttonAJIoannidisJPA, et al. (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. British Medical Journal343: d4002.
66.
SuzukiSItoD (2013) Psychological stress. In: GellmanMDTurnerJR (eds) Encyclopaedia of Behavioral Medicine. New York: Springer, pp. 1561.
67.
TesarNBaumhacklUKoppM, et al. (2003) Effects of psychological group therapy in patients with multiple sclerosis. Acta Neurology Scandinavia107(6): 394–399.
68.
ThomasPWThomasSHillierC, et al. (2006) Psychological interventions for multiple sclerosis. Cochrane Database of Systematic Reviews1: CD004431.
69.
WatsonTMFordEWorthingtonE, et al. (2014) Validation of mood measures for people with multiple sclerosis. International Journal of MS Care16(2): 105–109.
70.
ZiemssenT (2011) Symptom management in patients with multiple sclerosis. Journal of Neurological Science311: S48–S52.
71.
ZiemssenTThomasK (2017) Treatment optimization in multiple sclerosis: How do we apply emerging evidence?Expert Review of Clinical Immunology13(6): 509–511.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
